Adrenocorticotropic Hormone.

Adrenal cortical cells concentrate ascorbate through the sodium-dependent vitamin C transporter, and stimulation of the cortex is accompanied by ascorbate release from the gland. Ascorbate also acts as a reducing cofactor for the hydroxylation chemistry that steroid synthesis depends on. The link is a tissue-level physiological one and does not mean supplemental ascorbate changes hormone output.

Coenzyme A is built from pantothenic acid, cysteine and ATP, and acetyl-CoA supplies the carbon for cholesterol, the parent molecule of adrenal steroids. The steroidogenic response the hormone triggers therefore runs on a CoA-dependent supply line. This is cofactor supply and not evidence that pantothenate alters hormone signalling.

Glycyrrhizin and its metabolite glycyrrhetinic acid inhibit the enzyme that converts cortisol to inactive cortisone in mineralocorticoid target tissues. Cortisol then persists longer at those receptors, and because circulating cortisol provides the negative feedback signal to the pituitary, the axis that releases this hormone is part of the same loop. This is a well characterised pharmacological interaction and one of the clearest reasons licorice is flagged in stacks that touch the stress axis.

Phosphatidylserine has been studied for its effect on the pituitary and adrenal response to exercise stress, with the hormone measured as a marker of that response. A hormone concentration is a marker, not a clinical outcome. No paper in this ingredient's candidate list measured the pairing, so the confidence stays modest.

Ashwagandha is studied against markers of the stress axis, with cortisol and upstream pituitary signals as the measured variables. Because cortisol feeds back on the pituitary, anything that moves cortisol sits in the same loop as this hormone. What is measured in those studies is a marker, and a change in a marker is not by itself a change in how someone feels or functions.

Rhodiola is examined in the same stress-response framework, with hypothalamic-pituitary-adrenal markers as endpoints. The relationship to this hormone is through that shared axis rather than any direct binding or transport step. Marker data, not outcome data.

Vitamin D receptors are expressed in adrenal cortical tissue, and one indexed report argues that direct effects of supplemented vitamin D3 on the cortex are of secondary importance compared with indirect routes. The two therefore meet at the same target tissue. The cited work is preclinical in scope and grounds a mechanism, not a human effect.

The zona glomerulosa responds to potassium concentration and angiotensin II more than to pituitary signalling, while the zona fasciculata is the main pituitary-driven layer. Aldosterone output then governs renal potassium excretion, closing the loop. The relationship is anatomical and regulatory, within one gland.

Mineralocorticoid signalling from the adrenal cortex drives sodium reabsorption in the distal nephron, and cortisol contributes to that signal where the inactivating enzyme is inhibited or saturated. Sodium status in turn feeds back on the renin-angiotensin system that regulates the cortex. The connection is renal electrolyte handling, not a supplement pairing.